Alteration of the mare's immune system by the synthetic progestin, altrenogest

Autor: Kristina G Lu, Jessica M Hanneman, C. J. Corbin, Amanda A. Adams, C.E. Fedorka, Mats H.T. Troedsson, Olivia F. Walker, Alan J Conley, Barry A. Ball
Rok vydání: 2019
Předmět:
0301 basic medicine
Altrenogest
peripheral blood mononuclear cell
medicine.medical_treatment
animal diseases
Interleukin-1beta
altrenogest
Endometrium
chemistry.chemical_compound
0302 clinical medicine
Glucocorticoid
Pregnancy
Receptors
Leukocytes
cytokine
glucocorticoid receptor
Immunology and Allergy
Medicine
Progesterone
reproductive and urinary physiology
media_common
equine
030219 obstetrics & reproductive medicine
Obstetrics and Gynecology
Interleukin-10
medicine.anatomical_structure
Cytokine
Female
Trenbolone Acetate
Ovulation
medicine.drug_class
media_common.quotation_subject
Mononuclear
Clinical Sciences
Immunology
progesterone
Peripheral blood mononuclear cell
Andrology
Paediatrics and Reproductive Medicine
03 medical and health sciences
Interferon-gamma
Receptors
Glucocorticoid

Immune system
Animals
Horses
Obstetrics & Reproductive Medicine
business.industry
urogenital system
Interleukin-6
Animal
Horse
030104 developmental biology
Reproductive Medicine
chemistry
Leukocytes
Mononuclear

Pregnancy
Animal

Interleukin-4
business
Progestin
Zdroj: American journal of reproductive immunology (New York, N.Y. : 1989), vol 82, iss 2
Popis: Author(s): Fedorka, Carleigh Elizabeth; Ball, Barry A; Walker, Olivia F; Conley, Alan J; Corbin, Cynthia J; Lu, Kristina G; Hanneman, Jessica M; Troedsson, Mats HT; Adams, Amanda A | Abstract: ProblemProgestins are immunomodulatory in a variety of species. In the horse, the most commonly administered synthetic progestin is altrenogest (ALT), but its effect on the immune system of the non-pregnant mare is unknown.MethodsPeripheral blood mononuclear cells (PBMCs) from diestrous mares were incubated with varying concentrations of progesterone (P4) or ALT to assess intracellular production of IFNγ and the expression of select cytokines. Additionally, ten mares received either ALT or VEH daily utilizing a switchback design beginning on the day of ovulation and continuing for 7ndays. Circulating PBMCs and endometrial biopsies were obtained to assess the production and expression of the same cytokines.ResultsIn vitro, both P4 and ALT caused a dose-dependent decrease in intracellular IFNγ in PBMCs. P4 caused a dose-dependent decrease in the expression of IFNγ, IL-10 and IL-4, while ALT caused an increase in the expression of IL-6 and IL-1β in PBMCs. In vivo, ALT suppressed the intracellular levels of IFNγ in PBMCs on d6. While control mares experienced a decrease in IL-1β expression from d0 to d6, ALT-treated mares did not. In the endometrium, ALT increased the expression of IL-1RN and IFNγ in comparison with VEH-treated mares.ConclusionP4 and ALT appear to alter the immune system of the non-pregnant mare both systemically in addition to locally within the endometrium. Further research is necessary to determine the pathways through which this synthetic progestin functions on the immune system of the horse, and the consequences it may have.
Databáze: OpenAIRE